All figures reflect 2026 data. Costs cited are U.S. national averages or list prices verified against CMS, GoodRx, and published platform rates before publication; your locality, insurer, and provider will shift the actual number.
TL;DR — Quick Verdict
- A cash-pay medication management follow-up runs $100–$200 at most private psychiatry practices in 2026; the initial evaluation runs $250–$500.
- Medicare pays psychiatrists a fixed $135.61 for a moderate-complexity follow-up (CPT 99214) and $202.08 for a physician-led initial evaluation (CPT 90792) in 2026.
- Brightside’s cash psychiatry-only plan is $95/month; Talkiatry runs about a $30 copay through insurance — cheaper than most in-person self-pay visits.
- The medication itself is usually the smallest line item: generic sertraline and bupropion start near $8–$11 for a 30-day supply with a GoodRx coupon.
- Verdict: If you only need refills, a monthly cash platform or a low-copay insured visit beats paying $150+ per in-person follow-up — but confirm controlled-substance prescribing first.
Roughly one in eight U.S. adults takes an antidepressant, and nearly all of them sit through a recurring appointment that has almost nothing to do with the pill’s price tag. The visit — not the prescription — is where the money goes. A generic like sertraline can cost $7.54 for a month with a GoodRx coupon, yet the follow-up appointment to keep that prescription active often costs $150 or more out of pocket. That gap surprises most patients, and it drives the single biggest decision in ongoing psychiatric care: where to have the visit.
This article breaks down what a medication management visit actually costs in 2026 across three channels — private in-person psychiatry, insurance-billed visits, and online platforms like Brightside and Talkiatry — using published rates from the Centers for Medicare & Medicaid Services (CMS), GoodRx, and the platforms themselves. You’ll see the specific CPT codes that determine your bill, a year-one cost model, the drug prices that sit underneath it all, and where each option wins. If you’re weighing a prescriber against a talk-therapy provider, the psychiatrist vs therapist cost breakdown pairs naturally with this guide.
What a Medication Management Visit Costs in 2026
Price depends almost entirely on one thing: whether insurance is involved. Pay cash at a private practice and you shoulder the provider’s full fee. Use in-network insurance and you pay a copay while the plan pays a contracted rate. The spread between those two worlds is wide, and the table below maps it against the actual billing codes.
Medicare non-facility national rates from the CMS CY 2026 Physician Fee Schedule Final Rule; cash-pay ranges from GoodRx and Thervo (verify at cms.gov).
Two details drive the cash number. Provider type matters: a psychiatric nurse practitioner or physician assistant typically charges less than an MD psychiatrist for the same follow-up. Session length matters too — a 15-minute refill check sits at the bottom of the range, a 30-minute complexity visit near the top. Note that Medicare’s $135.61 for a 99214 is a fixed national baseline; commercial insurers often pay 90–120% of that figure, which is why an insured visit rarely mirrors the cash price.
How Billing Codes Decide Your Bill
Behind every medication management visit is a five-digit CPT code maintained by the American Medical Association, and that code — not the clock on the wall — sets what the visit is worth. Understanding the code your prescriber selects tells you whether you’re being billed accurately.
Consider a real scenario. You’re stable on escitalopram, you see your prescriber for a 20-minute check-in, nothing changes, and you leave with a refill. That’s a 99213: low-complexity, established patient, Medicare rate $95.19. Now change one fact — your prescriber increases the dose because your anxiety score climbed. Adjusting a prescription automatically counts as moderate risk in the coding rules, which pushes the visit to a 99214 at $135.61. The clinical work looks nearly identical to you, but the bill jumps roughly $40.
The initial visit follows a different logic. When a prescriber — a psychiatrist or a nurse practitioner with prescriptive authority — conducts your first evaluation and can prescribe in that same session, they bill 90792 at $202.08. A non-prescribing clinician doing the same intake bills 90791 at $173.35 because no medical service is attached. This is why the first appointment is always your most expensive: you’re paying for diagnosis, history, and a treatment plan in one sitting. Patients navigating a specific diagnosis often find the ADHD testing and medication cost guide useful, since evaluation coding there works the same way.
Online Platforms vs In-Person Psychiatry: Which Is Cheaper?
Online psychiatry reshaped the math for anyone whose main need is a prescription and periodic monitoring. Instead of a per-visit fee, most platforms bundle the prescriber, the visits, and the app into one monthly subscription — a model that can undercut in-person cash rates substantially.
Brightside Health, a common cash-pay choice, prices its psychiatry-only plan at $95/month, covering the initial evaluation and ongoing medication management, or $349/month for combined psychiatry plus four therapy sessions. Hims runs about $49/month billed quarterly but relies on asynchronous messaging rather than live video, which limits it for anyone new to medication. Talkiatry takes the opposite approach: it works exclusively through insurance, staffs board-certified psychiatrists, and lands most patients around a $30 copay per visit. The tradeoff is that Talkiatry won’t help you if you’re uninsured or out-of-network. For a fuller field, the online therapy platform cost comparison lays out subscription pricing side by side.
Platform pricing from Brightside Health and Talkiatry published rates, June–July 2026 (verify at brightside.com and talkiatry.com).
Verdict
For stable, non-controlled medication like an SSRI, a cash platform at $95/month or an insured visit near a $30 copay beats paying $150 per in-person cash follow-up — a subscription patient seen monthly spends about $1,140/year versus $1,800 at $150 per visit. But if you need a controlled substance such as a stimulant, choose a platform that prescribes them (Talkiatry) or an in-person psychiatrist; Brightside and Hims will not. In-person care still wins when symptoms are severe or a physical exam matters.
The Prescription Itself: Why the Drug Is the Cheap Part
Patients bracing for a big pharmacy bill are usually relieved. Most first-line psychiatric medications went generic years ago — sertraline’s patent expired in 2006, escitalopram’s in 2012 — and competition has driven cash prices to single digits. The visit that authorizes the prescription now costs far more than the prescription.
Here’s what the common generics run for a 30-day supply in 2026, using published GoodRx cash and coupon prices.
Generic cash and coupon starting prices from GoodRx, prices last updated July 2026 (verify at goodrx.com).
Two caveats keep this from being universal. Brand-name versions still cost a fortune — brand Zoloft can run $440–$560 monthly — so a prescriber writing “dispense as written” for a brand changes the picture entirely. And a few newer agents haven’t gone generic yet. But for the antidepressants most patients start on, the drug is a rounding error next to the appointment. Big-box pharmacies like Walmart and Costco push some of these onto $4 generic lists, cheaper still.
What Most People Get Wrong About These Costs
Three assumptions cost patients real money, and each is avoidable once you know the mechanics of how these visits are billed and paid.
Mistake one: assuming insurance always beats cash. With a high-deductible plan — and roughly 44% of Americans have one — you pay the full contracted rate until the deductible is met. That contracted rate can exceed a cash platform’s monthly fee. The fix: before your first visit, ask your plan what a 99214 pays under your specific benefits, then compare it to a $95 subscription.
Mistake two: paying brand prices by accident. A prescription written for the brand instead of the generic can multiply your pharmacy bill fortyfold. The consequence is a $500 monthly drug cost that a one-word change would erase. Ask your prescriber to write for the generic unless there’s a documented clinical reason not to, and run the drug through GoodRx before you pay.
Mistake three: overpaying on visit frequency. Once medication is stable, many patients are seen every one to three months, not monthly. Booking — and paying for — monthly follow-ups you don’t clinically need inflates your annual total by hundreds of dollars. The correct action is to confirm the recommended cadence with your prescriber rather than defaulting to the most frequent option. If cost is the barrier, low-cost sliding scale options and federally qualified health centers price by income.
Is Ongoing Medication Management Worth Paying For?
Skipping follow-ups to save money is a false economy for anyone on psychiatric medication, but the right channel depends on your situation. The decision comes down to insurance status, medication type, and symptom severity.
If you have in-network mental health coverage, use it: an insured visit at a specialist copay — which averaged $45 in 2025 per KFF — is almost always cheaper than cash, and the Mental Health Parity and Addiction Equity Act requires plans to cover psychiatric care comparably to physical care. If a claim gets denied, the mental health parity appeals process is your recourse.
If you’re uninsured and take a stable, non-controlled medication, a cash subscription platform is the value play — predictable monthly cost, no per-visit surprises. If you take a controlled substance, need close monitoring, or have complex symptoms, pay for an in-person prescriber who can adjust treatment and order labs. And if your prescriber and a separate therapist are both in the picture, map the combined spend against the therapy costs by provider type before committing, and check whether in-network versus out-of-network status shifts your math.
The unifying rule: the appointment is the cost driver, the medication rarely is. Optimize the visit — its channel, its frequency, its billing code — and the rest follows.
Frequently Asked Questions
How much does a medication management follow-up cost without insurance?
At most private psychiatry practices in 2026, a cash-pay follow-up runs $100–$200, with brief 15-minute check-ins near $75 and longer complexity visits up to $200 or more, per GoodRx and Thervo data. Online cash subscriptions like Brightside bundle these into a $95/month plan, which can be cheaper if you’re seen frequently.
Does the appointment or the medication cost more?
The appointment, by a wide margin. A generic like sertraline starts at $7.54 for a 30-day supply with a GoodRx coupon, while a single follow-up visit typically costs $100–$200 out of pocket. Most first-line psychiatric generics cost only a few dollars monthly because they lost patent protection years ago.
Can online platforms prescribe controlled substances like Adderall?
Some can, some can’t. Talkiatry, which staffs board-certified psychiatrists and works through insurance at roughly a $30 copay, can prescribe controlled substances. Brightside ($95/month cash) and Hims ($49/month) do not prescribe them. If you need a stimulant or benzodiazepine, verify the platform’s policy before signing up or choose an in-person prescriber.
What’s the difference between a 99213 and 99214 on my bill?
A 99213 is a low-complexity established-patient visit (Medicare 2026 rate $95.19), typically a stable refill. A 99214 is moderate complexity ($135.61) and applies when a prescription is started, stopped, or adjusted — medication changes automatically qualify as moderate risk. The roughly $40 gap explains most billing questions patients raise.
How We Researched This Article
This guide combines federal reimbursement data, published pharmacy pricing, and platform-stated rates to model what a medication management visit and its prescription actually cost a patient in 2026. Visit reimbursement figures come from the Centers for Medicare & Medicaid Services CY 2026 Physician Fee Schedule Final Rule, which sets the national non-facility payment for each CPT code (99213, 99214, 90791, and 90792) using the 2026 conversion factor of approximately $33.40. These are measured, published rates, not estimates.
Cash-pay visit ranges were drawn from consumer price transparency sources including GoodRx and healthcare cost aggregators, cross-checked against multiple 2026 practice guides. Because private cash fees vary by provider, license type, geography, and session length, these are reported as ranges rather than single points. Drug prices reflect starting cash and coupon prices published by GoodRx and last updated in July 2026; actual pharmacy prices vary by dose, quantity, and location. Platform subscription pricing was taken directly from Brightside Health and Talkiatry published rates. Copay context references the Kaiser Family Foundation (verify at kff.org) 2025 employer benefits data. Parity coverage references the American Medical Association’s CPT framework and federal parity law.
Limitations: reimbursement rates are national baselines subject to Geographic Practice Cost Index adjustments of roughly 10–20%, commercial insurer rates are negotiated and not publicly fixed, and controlled-substance prescribing policies change. Where figures are modeled (annual cost projections) versus measured (CMS rates, list prices), the text says so. This research was last conducted in July 2026. All figures were verified against named primary sources before publication.